American Capital Advisory’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
AI
American Capital Advisory's BIO Position: Q2 2026 in Review
American Capital Advisory opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 2 shares worth $588. The stake represents ﹤0.01% of the portfolio and ranks #919 among its holdings. This is a return to the name: American Capital Advisory previously reported a position in BIO as recently as Q1 2025.
American Capital Advisory first reported a position in BIO in Q1 2025 and has held it in 2 quarters since. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.
- American Capital Advisory held 2 shares of Bio-Rad Laboratories Class A worth $588 as of Q2 2026.
- Bio-Rad Laboratories Class A was a new American Capital Advisory position in Q2 2026.
- Bio-Rad Laboratories Class A made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #919 holding.
- American Capital Advisory first reported a position in Bio-Rad Laboratories Class A in Q1 2025 and has held it in 2 quarters since.
- 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.
Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.